High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy

Pinto Lab - Baker Heart and Diabetes Institute

Abstract

Background: Cardiac fibrosis is a key antecedent to many types of cardiac dysfunction including heart failure. Physiological factors leading to cardiac fibrosis have been recognized for decades. However, the specific cellular and molecular mediators that drive cardiac fibrosis, and the relative impact of disparate cell populations on cardiac fibrosis, remain unclear.

Methods: We developed a novel cardiac single-cell transcriptomics strategy to characterize the cardiac cellulome—the network of cells that forms the heart. This method was utilized to profile the cardiac cellular ecosystem in response to two weeks of continuous administration of Angiotensin II, a pro-fibrotic stimulus which drives pathological cardiac remodeling.

Results: Our analysis provides a comprehensive map of the cardiac cellular landscape uncovering multiple cell populations that contribute to pathological remodeling of the extracellular matrix of the heart. Two phenotypically distinct fibroblast populations—Fibroblast- Cilp and Fibroblast-Thbs4—emerged after induction of tissue stress to promote fibrosis in the absence of smooth muscle actin-expressing myofibroblasts, a key pro-fibrotic cell population. Following Angiotensin II treatment, Fibroblast-Cilp develops as the most abundant fibroblast subpopulation and the predominant fibrogenic cell type. Mapping intercellular communication networks within the heart, we identified key intercellular trophic relationships and shifts in cellular communication after Angiotensin II treatment, that promote development of a profibrotic cellular microenvironment. Further, the cellular responses to Angiotensin II and the relative abundance of fibrogenic cells were sexually dimorphic.

Conclusions: These results offer a valuable resource for exploring the cardiac cellular landscape in health and after chronic cardiovascular stress. These data provide insights into the cellular and molecular mechanisms that promote pathological remodeling of the mammalian heart, highlighting early transcriptional changes which precede chronic cardiac fibrosis.

Download

Name Sample Attributes Variables Assay
ENA Source Name organism strain age developmental stage sex genotype organism part cell type compound dose Assay Name
ERR3971669 AP18002 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte none AP18002
ERR3971663 AP18003 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte angiotensin II 1.5 (milligram per kilogram per day) AP18003
ERR3971667 AP18004 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte saline 1.5 (milligram per kilogram per day) AP18004
ERR3971664 AP18005 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte angiotensin II 1.5 (milligram per kilogram per day) AP18005
ERR3971670 AP18006 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte none AP18006
ERR3971665 AP18007 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte angiotensin II 1.5 (milligram per kilogram per day) AP18007
ERR3971668 AP18008 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte saline 1.5 (milligram per kilogram per day) AP18008
ERR3971666 AP18009 Mus musculus C57BL/6J 10 (week) adult mixed wild type genotype heart cardiac non-myocyte and cardiomyocyte angiotensin II 1.5 (milligram per kilogram per day) AP18009